43388
Esterase Isoenzyme 1 porcine liver, recombinant
recombinant, expressed in E. coli, ≥30.0 U/g
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
CAS Number:
MDL number:
UNSPSC Code:
12352204
EC Number:
232-773-7
NACRES:
NA.54
Specific activity:
≥30.0 U/g
Recombinant:
expressed in E. coli
recombinant
expressed in E. coli
Quality Level
form
crystalline, crystals, powder or flakes
specific activity
≥30.0 U/g
storage temp.
−20°C
Application
Esterase Isoenzymes may be used to identify the monocytic element in normal and leukemic cells. They may be used for the biochemical characterization of different hematopoietic cell lineages and stages of differentiation when studying leukemias and lymphomas. Esterase Isoenzyme 1, product 43388, is recombinant and from porcine liver. It is expressed in E. coli.
Biochem/physiol Actions
An esterase is a hydrolase that splits esters into acids and alcohols.
Packaging
Bottomless glass bottle. Contents are inside inserted fused cone.
Other Notes
1 U corresponds to the amount of enzyme which converts 1 μmol 4-nitrophenyl-L-acetate per minute at pH 7.5 and 30°C.
signalword
Danger
hcodes
pcodes
Hazard Classifications
Resp. Sens. 1
Storage Class
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
H G Drexler et al.
Cancer, 59(1), 77-82 (1987-01-01)
The expression of a particular alpha-naphthyl acetate esterase isoenzyme which is specific for monocytes was examined in a panel of cultured leukemia-lymphoma cell lines (n = 88), freshly obtained leukemia-lymphoma cells (n = 527), and in fresh (n = 10)
Esterase isoenzyme profiles of 255 leukemia-lymphoma cell lines from all hematopoietic cell lineages.
SM Gignac, ZB Hu, et al.
Leukemia Lymphoma, 22, 143-151 (1996)
Marie C Fortin et al.
Drug metabolism and disposition: the biological fate of chemicals, 41(2), 326-331 (2012-12-12)
Studies on therapeutic drug disposition in humans have shown significant alterations as the result of pregnancy. However, it is not known whether pesticide metabolic capacity changes throughout pregnancy, which could affect exposure of the developing brain. We sought to determine